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Hematopoietic Stem Cells Localize
to the Endothelial Cell Layer
in the Midgestation Mouse Aorta
vertebrates analyzed, clusters of hematopoietic cells
have been observed along the vitelline and umbilical
arteries as well as the ventral wall of the dorsal aorta
(Garcia-Porrero et al., 1995; Shalaby et al., 1997; Tavian
et al., 1999; Wood et al., 1997), suggesting that hemato-
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poietic cell emergence occurs in close association withRotterdam
the major vasculature of the embryo.Netherlands
Indeed, many years ago, based on microscopic obser-2 Department of Hematology
vations of yolk sac blood islands, it had been proposedCambridge University
that there exists a common mesodermal precursor cell,CIMR Centre
the hemangioblast, for hematopoietic and endothelialCambridge
lineages (Murray, 1932). Gene targeting experimentsUnited Kingdom
have yielded some insight into the relationship between
these lineages and have shown that the Flk-1 receptor
tyrosine kinase, for example, is required for develop-Summary
ment of both the endothelial lineage and the hematopoi-
etic lineage (Shalaby et al., 1997). However, unlike theThe emergence of the first adult hematopoietic stem
coordinated emergence of hematopoietic and endothe-cells (HSCs) during mammalian ontogeny has been
lial cells in the yolk sac, the dorsal aorta is formed beforeunder intense investigation. It is as yet unresolved
the emergence of adult repopulating HSCs, suggestingwhether these first HSCs are derived from intraembry-
a slightly different type precursor or hemangioblast. Im-onic hemangioblasts, hemogenic endothelial cells, or
munohistochemical analyses of the AGM region revealother progenitors. Thus, to examine the spatial gener-
overlap in the expression of hematopoietic and endothe-ation of functional HSCs within the mouse embryo,
lial markers in the clusters of cells that appear to bewe used the well-known HSC marker, Sca-1, and a
emerging from the ventral wall of the dorsal aorta (Mar-transgenic approach with an Ly-6A (Sca-1) GFP
shall and Thrasher, 2001). The most interesting expres-marker gene. Our results show that this transgene
sion pattern is exhibited by the Runx1 (previously knownmarker is expressed in all functional HSCs in the mid-
as Cbfa2 or AML1) transcription factor (North et al.,gestation aorta. Immunohistology of aorta-gonads-
1999), which has been shown to be required for HSCmesonephros (AGM) regions show that GFP cells are
activity in the AGM but does not appear to affect thespecifically localized to the endothelial layer lining the
major vasculature or early yolk sac hematopoiesis (Caiwall of the dorsal aorta but not to the mesenchyme,
et al., 2000; Wang et al., 1996; Okuda et al., 1996; Mukou-strongly suggesting that HSC activity arises within a
yama et al., 2000). At embryonic day 10 (E10), Runx1few cells within the endothelium of the major vascu-
expression is found in the hematopoietic clusters andlature.
endothelial cells lining the walls of the vitelline and um-
bilical arteries and the ventral wall of the dorsal aortaIntroduction
(North et al., 1999). Additionally, expression is found in
some mesenchymal cells underlying the ventral endo-During adult stages, the vertebrate hematopoietic sys-
thelial cells of the dorsal aorta. Taken together, thesetem is constantly renewed from hematopoietic stem
studies suggest that adult repopulating HSCs are de-
cells (HSCs) harbored in the bone marrow. These HSCs
rived from precursors within the hematopoietic clusters,
are characterized by functional repopulation properties
endothelium, and/or underlying mesenchyme, and only
elaborated after transplantation into adult recipients de- the use of further markers will yield a precise identifica-
pleted for endogenous hematopoietic activity. The de- tion of the HSC precursor. Recently, flow cytometric
fining characteristics of HSCs are long-term, high level sorting of Runx1 positive cells together with combina-
repopulation of all hematopoietic lineages and the ability tions of antibodies recognizing other marker proteins
to self-renew (Lemischka, 1991; Spangrude et al., 1991). on hematopoietic, endothelial, and mesenchymal cells
During ontogeny, the first adult-type HSCs arise in the has supported a mesenchymal and/or endothelial origin
aorta-gonads-mesonephros (AGM) region, as shown by for HSCs (North et al., 2002 [this issue of Immunity]).
direct transplantation of AGM cells into adult recipients For many years, the Sca-1, GPI-linked cell surface
(Muller et al., 1994) or by transplantation of such cells glycoprotein has been used as a faithful marker of mu-
after AGM explant culture (Medvinsky and Dzierzak, rine HSCs from various sources; i.e., adult bone marrow,
1996). Further investigation of HSC emergence within fetal liver, and yolk sac (Spangrude et al., 1988; Huang
the embryo has demonstrated their presence in the re- and Auerbach, 1993). Sorting on the basis of the mono-
gions of major vasculature: the vitelline and umbilical clonal antibody E13-161.7 specific for the Sca-1 epitope
arteries and the dorsal aorta (de Bruijn et al., 2000). yields about a 100-fold enrichment of HSCs from adult
Furthermore, within all mammalian and nonmammalian bone marrow (Okada et al., 1992; Spangrude et al.,
1988). Sca-1 is encoded by the strain specific allelic
genes, Ly-6E and Ly-6A (Khan et al., 1990; Sinclair and3 Correspondence: dzierzak@ch1.fgg.eur.nl
4 These authors contributed equally to this work. Dzierzak, 1993; Stanford et al., 1992; van de Rijn et al.,
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1989), which are members of the large Ly-6 gene family and a Sca-1 population (data not shown). Thus, the
c-kit marker can provide a further enrichment for E11(Kamiura et al., 1992; LeClair et al., 1986). Sca-1 protein
expression is complex within Ly-6A and Ly-6E strains AGM HSCs.
of mice (Kimura et al., 1984; Spangrude and Brooks,
1993; van de Rijn et al., 1989). Ly-6A strains of mice The Ly-6A GFP Transgene Marks All Functional
express Sca-1 on virtually all (99%) of marrow-repopu- HSCs from the E11 AGM Region
lating cells from the adult bone marrow, while Ly-6E To study HSC generation and localization within the
strains express Sca-1 on only 25% of these cells (Span- midgestation mouse embryo, we generated transgenic
grude and Brooks, 1993). Despite the allelic differences, mice expressing the GFP reporter gene under the con-
the Sca-1 marker should be useful in identifying and trol of the Ly-6A gene regulatory sequences. The en-
localizing the first HSCs as they emerge in the AGM hanced GFP gene was inserted into the first untranslated
region. The relatively small size of the Ly-6A/E gene exon of the Ly-6A gene (Figure 1C) and was flanked by
locus (14 kb) which contains all the transcriptional regu- 4 kb of upstream and 10 kb of downstream genomic
latory elements of these alleles (Khan et al., 1990, 1993; sequences containing regulatory elements shown to be
McGrew and Rock, 1991; Sinclair and Dzierzak, 1993; necessary for high level specific expression in trans-
Ma et al., 2001; Sinclair et al., 1996) has been useful in genic mice (Ma et al., 2002).
directing lacZ marker gene expression in bone marrow Since all adult repopulating bone marrow HSCs were
HSCs in transgenic mice (Miles et al., 1997; Ma et al., found to express the Ly-6A GFP transgene, yielding up
2002). to a 100-fold enrichment of HSCs (data not shown), we
Thus, to identify the lineage of cells from which the explored whether transgene expression could be used
first functional HSCs emerge in the AGM region, we to enrich for HSCs from the AGM region. Sorting experi-
performed studies using the Sca-1 surface glycoprotein ments were performed on Ly-6A GFP E11 AGM cells.
marker and the enhanced green fluorescent protein Approximately 1.7% (range 1.5%–2.0%) of AGM cells
(GFP) marker within the context of an Ly-6A transgene are GFP (Figure 1D). Sorted GFP and GFP cells were
in midgestation mouse embryos. We report here that transplanted at cell doses of 2, 1, and 0.3 ee (average
while only some AGM HSCs express the Sca-1 protein, of 3  103 GFP cells/ee). At greater than 4 months
all AGM HSCs are positive for expression of GFP from posttransplantation, 10% donor cell engraftment
the Ly-6A GFP transgene. Immunohistological analyses (ranging from 15% to 70%) was found in recipients re-
reveal expression of the GFP marker within a single layer ceiving either 1 or 2 ee of GFP cells (Figure 1E). No
of cells lining the wall of the dorsal aorta and the vitelline/ donor-derived repopulation was found with 0.3 ee of
umbilical arteries. Together with functional data demon- GFP cells or any dose of GFP cells. Thus, unlike the
strating the presence of HSC activity exclusively in the Sca-1 marker, Ly-6A GFP transgene expression marks
GFP positive fraction of the aorta region, our results all HSCs in the AGM region.
strongly suggest that the first HSCs within the midgesta-
tion embryo are localized within the endothelial cell layer All E11 AGM HSCs Are Localized to the GFP
lining the wall of the dorsal aorta. Population in the Aorta Region
While previous E11 AGM subdissection studies demon-
strated that HSCs are present in the region of the aortaResults
with its surrounding mesenchyme (de Bruijn et al., 2000),
we tested whether such cells could be further enrichedThe Sca-1 Antigen Is Expressed on Some AGM HSCs
To examine whether the Sca-1 antigen is expressed on based on GFP expression. We performed flow cytomet-
ric sorting and transplantation of GFP cells from theAGM HSCs, we sorted Sca-1 cells from E11 AGM cell
suspensions and performed transplantation experi- aorta-mesenchyme subregion of E11 Ly-6A GFP em-
bryos. The aorta-mesenchyme contained on averagements to test for functional hematopoietic repopulation
of irradiated adult recipient mice by the donor cells. A 1.9% (1.4% to 3.0% GFP cells; see Figure 2A, left
panel). Long-term adult repopulating HSC activity (Fig-representative fluorescence profile (Figure 1A) shows
that 3.8% (range 1.95%–3.9%) of E11 AGM cells are ure 2A, right panel) was found in the GFP fraction of
the aorta-mesenchyme when 1 or 2 ee of GFP cells wasSca-1. At greater than 4 months posttransplantation,
recipients were tested for the presence of donor cells transplanted (average of 1.6  103 GFP cells/aorta-
mesenchyme). No donor cell engraftment was foundby PCR of peripheral blood DNA (donor cell marker is
a lacZ or human -globin transgene). When transplanted when the GFP fraction was transplanted. Engraftment
of recipients, as measured by peripheral blood DNA PCRat 1 embryo equivalent (ee) of sorted cells per recipient,
adult repopulating HSCs were found in both the Sca-1 for the donor cell GFP marker at greater than 4 months
posttransplantation, ranged from 11% to 100% (dataand Sca-1 fractions (Figure 1B) (donor engraftment
ranging from 15% to 38%). This result may reflect a low not shown).
To determine whether donor cell hematopoietic en-or negative expression of Sca-1 by some HSCs as they
emerge in the E11 AGM. graftment was multilineage, flow cytometric analysis
was performed on peripheral blood cells. Representa-Previously, we had shown that all E11 AGM HSCs are
c-kit (Sanchez et al. 1996). To further subfractionate tive data of one recipient at 2 months posttransplanta-
tion is shown in Figure 2C (bottom panels). GFP expres-AGM HSCs, we sorted E11 AGM cells on the basis of
c-kit and Sca-1 antigen expression. In these experi- sion was found in B220, CD4/8, and Mac-1
fractions, thus revealing the donor derivation of 35% ofments, we confirm that all functional adult repopulating
HSCs are c-kit and that they are divided into a Sca-1 the monocytes, 18% of the B cells, and 5.3% of the T
HSCs in the Endothelium
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Figure 1. Characterization of E11 AGM Adult
Repopulating HSCs for Expression of the
Sca-1 Antigen or Ly-6A GFP Transgene
(A) E11 AGM region cells were stained with
the Sca-1 PE antibody and sorted into Sca-
1 and Sca-1 fractions. Percentages in each
fraction are indicated.
(B) One embryo equivalent of each fraction
of Sca-1 (1.0  104) and Sca-1 (25.3  104)
cells was injected into adult recipient mice,
and after 4 months peripheral blood DNA was
examined for the presence of donor cells. The
number of repopulated animals/total number
of animals transplanted is indicated above
each column (percentage of recipients re-
populated is indicated on y axis). Only those
animals with 10% donor cells are consid-
ered positive. Engraftment of recipients by
donor-derived cells as measured by periph-
eral blood DNA PCR ranged from 15%–38%
for Sca-1 sorted cells and 16%–36% for
Sca-1 sorted cells. Results are from four in-
dependent experiments.
(C) Ly-6A GFP transgene construct. The 14
kb BamHI fragment of the Ly-6A gene and
the insertion of the enhanced GFP gene into
the Cla1 cloning site is shown. Restriction
sites are indicated. B, BamH1; Bg, BglII; K,
Kpn1; R, EcoR1; H, HindIII; X, Xba1.
(D) Flow cytometric profile for E11 Ly-6A GFP
transgenic AGM cells, with percentages of
cells within the sorting gates indicated.
(E) Long-term repopulation of recipients (4
months posttransplantation) receiving 1 or 2
ee of either GFP or GFP sorted E11 AGM
cells. One ee of sorted E11 GFP AGM cells
is on average 3  103 cells, and one ee of GFP cells is 17.0  104 . The number of repopulated animals/total number of animals transplanted
is indicated above each column (y axis shows percentage of recipients repopulated). Only those recipients with greater than 10% donor
positive cells are considered positive. Engraftment ranged from 15%–70% as measured by peripheral blood DNA PCR for the donor cell GFP
marker. Results are from four independent experiments.
cells as compared to the control transgenic (top panels). (Figure 3D), GFP fluorescence of dorsal aorta cells ap-
peared to be of lower intensity (Figure 3C). However,Furthermore, at greater than 4 months posttransplanta-
tion, donor marker DNA PCR analysis on two other recip- as revealed in transverse sections through the E11 (43
somite pairs [sp]) dorsal aorta (Figure 3F), only a singleients transplanted with GFP aorta-mesenchyme cells
revealed repopulation in all hematopoietic tissues and layer of cells interspersed along the circumference of
the aorta was found to be GFP (Figure 3E). No GFPlineages tested (Figure 2D). Engraftment ranged from
21% to 100%. Thus, all long-term, multilineage adult expression was found in the mesenchymal tissue di-
rectly surrounding the dorsal aorta. GFP expression inrepopulating HSCs from the E11 aorta-mesenchyme can
be isolated and enriched within the GFP fraction. the dorsal aorta was found beginning at E9 (24 sp stage)
and is confined to only a very few cells in the ventral
wall (data not shown). Expression in the aorta becomesThe Temporal and Spatial Expression Pattern
of Ly-6A GFP Is Correlated with Sites more widespread, first along the ventral and then along
the dorsal wall at E10 and E11, respectively, and contin-of HSC Generation
The general expression pattern of the Ly-6A GFP trans- ues until at least E14. In contrast to the dorsal aorta, no
GFP expression was observed in the whole yolk sac atgene could be visualized with fluorescence and confocal
microscopy. When marker transgene expression was E9 or E10 (34 sp stage; Figures 3G and 3H). However,
at late E11 (48 sp stage; Figures 3I and 3J) GFP cellsexamined in the late E11 AGM region, we found highly
fluorescent GFP cells in the mesonephric tubules and could be found in the yolk sac but only on very few of
the large vessels. Expression in the yolk sac vesselsthe Wolffian/Mullerian ducts (Figures 3A and 3B), as we
had found previously for the Ly-6A lacZ transgene (Ma et continues at least until E14. Most interestingly, high level
GFP expression was found in both the vitelline (Figuresal., 2002). However, in contrast to Ly-6A lacZ transgenic
embryos, we also found punctate GFP expression in the 3K and 3L) and umbilical arteries (data not shown) at E10
(38 sp stage). GFP expression in these vessels begins atcells along the wall of the dorsal aorta (Figures 3A and
3C). Confocal microscopy revealed the GFP-expressing E9 (24 sp stage) and continues at least until E14 (Figures
3M and 3N). Of the vitelline vessels, high level GFPcells to be dispersed along the circumference and length
of the E11 dorsal aorta (Figures 3A and 3C). Compared to expression appears to be confined to the artery.
Other sites in the midgestational Ly-6A GFP embryothe mesonephric tubules in the urogenital ridges (UGR)
Immunity
676
Figure 2. Long-Term Adult Repopulation by GFP-Sorted Cells from E11 Tissues
(A and B) In the left panels flow cytometric profiles and sorting gates are shown for (A) E11 aorta-mesenchyme and (B) UGR, liver, and limb
bud cells. The percentage of GFP cells for each tissue is indicated. In the right panels the results of transplantation of these sorted cells is
shown. The x axis of the bar charts indicates the number of embryo equivalents of each sorted cell population that was transplanted. One
ee of GFP cells from the aorta-mesenchyme is on average 1.6  103 (range 1.3 to 2.1  103), and one ee of GFP cells is 9  104 (range
810  104). The bars represent the percentage of recipients found positive for donor repopulation at 4 months posttransplantation. The
number of recipients repopulated/total number of recipients is indicated for each bar. Donor cell engraftment, as measured by peripheral
blood DNA PCR ranged from 11% to 100%.
(C) Flow cytometric analysis of peripheral blood from a normal adult Ly-6A GFP transgenic control and a GFP aorta cell transplant recipient.
GFP fluorescence is on the x axis, and phycoerythrin fluorescence is on the y axis. Directly conjugated phycoerythrin B220-, CD4-, CD8-, and
Mac-1-specific antibodies were used for blood cell staining. Percentage of double-positive cells is indicated in the upper right quadrants.
(D) Hematopoietic multilineage analysis of two recipient mice repopulated with GFP aorta-mesenchyme cells. At 4 months posttransplanta-
tion, DNA was isolated from peripheral blood (PB), bone marrow (BM), bone marrow myeloid cells (bM), bone marrow B cells (bB), spleen (S),
spleen B cells (sB), spleen T cells (sT), thymus (Th), and lymph nodes (L). PCR analysis was performed using oligonucleotide primers for GFP
(top band) and myogenin (myo) (lower band) genes. One hundred, seventy-five, fifty, twenty-five, ten, one, and zero are the contribution
controls indicating percentage donor cell engraftment. Percentage engraftment by donor cells (indicated below each gel) was calculated by
ImageQuant. Transplantation data are from two independent experiments.
were found to express GFP and include the liver, hind- the dorsal aorta may represent. Transverse sections
through the trunkal regions of E11 Ly-6A GFP embryosgut, and limb buds (data not shown). These GFP tissues
were tested for HSC activity. Flow cytometry (Figure were stained using antibodies to CD31 (PECAM-1), a
marker expressed on all endothelial cells and on in-2B, left panels) revealed that these tissues contained
between 2% and 4.2% GFP cells. As shown in Figure traaortic hematopoietic clusters (Cai et al., 2000; Drake
and Fleming, 2000; Garcia-Porrero et al., 1998), and2B (right panels), no HSCs (GFP or GFP) were found
in the E11 UGRs or the limb buds. However, HSCs of Sca-1. Low magnification of a transverse section
through the trunkal region of an E11 Ly-6A GFP embryothe E11 liver were exclusively in the GFP fraction. Thus,
all HSCs are GFP but not all GFP cells are HSCs. stained with CD31 shows a single layer of CD31 (red;
Cy5) endothelial cells lining the entire circumference of
the dorsal aorta (Figures 4A and 4B). GFP expressionLy-6A GFP Expression Is Localized to the Endothelial
Cell Layer of the Midgestation Dorsal Aorta appears to be colocalized within a few of these endothe-
lial cells. High magnification of the ventral area withinImmunohistochemical staining was performed to es-
tablish what cell lineage(s) the GFP-expressing cells in the box shows single green and red fluorescence signals
HSCs in the Endothelium
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Figure 3. Fluorescent Microscopic Analysis of Whole AGM and Tissue Sections from Ly-6A GFP Embryos
(A) Confocal microscopic analysis of whole late E11 AGM tissue at 10 magnification. Twenty-four scanned images of this AGM region were
obtained at 10 m intervals. The scanned image in this figure is the 12th optical slice of 24 with a thickness of approximately 1 m. All 24
images of the Z stack of this AGM were used to build the three-dimensional projection shown at www.eur.nl/fgg/ch1 (see Cell Biology).
(B) Schematic drawing of the GFP expression region of the E11 AGM shown in (A). GFP positive areas include the aorta, mesonephric tubules,
and Wolffian/Mullerian ducts.
(C and D) GFP fluorescent image of a portion of the E11 aorta (C) and mesonephric tubules (D) at 20 magnification, 1 m thickness.
(E and F) Fluorescent (E) and bright field (F) images of a transverse section of the AGM region of a 43 somite pair (sp) transgenic embryo
(E11) showing the dorsal aorta. Dorsal side is up and ventral is down. A single-cell layer of interspersed GFP cells is found only around the
circumference of the dorsal aorta and is indicated by the arrowheads. Magnification 10.
(G and H) Fluorescent (G) and bright field (H) images of a yolk sac from a 34 sp transgenic embryo (E10). No fluorescent signal is detected
in the yolk sac, particularly the vessels. Magnification 4.
(I and J) Fluorescent (I) and bright field (J) images of a yolk sac from a 48 sp transgenic embryo (E11). GFP signal is found in the cells lining
the large vessel. Arrowheads indicate the vessel walls.
(K and L) Fluorescent (K) and bright field (L) images of the vitelline vessels as they emerge from the body wall (B) of a 38 sp transgenic embryo
(E10). Strong GFP signal is observed in the vitelline artery (Va) with some low signal in the underlying vein (Vv). The fluorescent negative yolk
sac (YS) is shown in the background. Magnification 4.
(M and N) Fluorescent (M) and bright field (N) images of the vitelline vessels from an E14 transgenic embryo. The endothelial cells of the
vitelline artery (Va) are strongly GFP positive. Magnification 4.
(Figures 4E and 4F). An overlay of both signals (Figure of the cells within the single-cell layer of endothelial
cells lining the dorsal aorta, and these cells express the4G) reveals GFP expression (green) within the cytoplasm
and the red signal of the CD31 antibody on the surface CD31 endothelial/hematopoietic cluster marker.
Finally, the expression of GFP and endogenous Sca-1of a pair of double-positive cells (see arrow, Figure 4G).
The two adjacent cells are located within the single layer was examined by fluorescent microscopy on transverse
sections through the trunkal region of E11 Ly-6A GFPof cells lining the aorta. A third double-positive cell is
seen further to the right. Unfortunately, while we exam- embryos. As shown in Figure 4C (GFP expression) and
D (GFP and Sca-1 expression), Sca-1 expression clearlyined many of these transverse sections to evaluate the
GFP expression status, we were unable to find any he- overlaps with the GFP signal in the mesonephric tubules.
However, no (or undetectable) Sca-1 expression wasmatopoietic clusters. Thus, from the results presented
here, GFP expression is specifically localized to a few found in the GFP cells lining the walls of the dorsal
Immunity
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Figure 4. Fluorescence and Immunostaining Confocal Microscopic Analysis of AGM Tissue Sections from Ly-6A GFP Embryos
(A and B) Fluorescence microscopic image (A) and bright field image (B) of a transverse section through the dorsal aorta of an E11 (43 somite
pair) embryo, showing immunofluorescent staining with an antibody against CD31 (red) and GFP transgene signal (green). Part of the ventral
wall of the aorta (marked by a box) is shown at a higher magnification in (E) GFP signal, (F) CD31 Cy5 signal, and (G) an overlay of GFP and
CD31 signals. The arrow indicates two adjacent cells that coexpress the Ly-6A GFP transgene and CD31. Arrowheads indicate some of the
autofluorescent erythrocytes.
(C) Transverse section through an E11 AGM region showing a single layer of GFP cells (green) around the dorsal aorta (and strongly fluorescent
mesonephric tubules). Ventral is to the upper right.
(D) Sca-1 (red) and GFP immunofluorescence on section as shown in (C). Overlap in expression of Sca-1 and GFP occurs in the mesonephric
tubules, but no (or undetectable) overlap is found in aorta cells. Size bars are included for (A), (E), (F), and (G), and (C) and (D) are at a 40
magnification.
(E–G) For (E), (F), and (G) (CD31 immunostaining), optical slice eight from 18 optical scans of approximately 1 m thickness at 0.5 m intervals
is shown. All 18 optical slices, respectively, were used to build the three-dimensional projection shown at www.eur.nl/fgg/ch1 (see Cell
Biology).
aorta, suggesting that either expression or the sensitivity in the aorta-mesenchyme fewer GFP cells coexpress
Sca-1 (19%). This is in accordance with the immuno-of detection is more limited for the endogenous Sca-1
antigen than for GFP fluorescence. histochemical and transplantation results and sug-
gesting that cell surface Sca-1 antigen expression is
limited on cells of the aorta and particularly on HSCs.GFP Aorta Cells Express Additional Endothelial
and Hematopoietic Markers We next examined the expression of c-kit, CD34,
CD31, and VE-cadherin on cells from these subregions.Since we have shown that hematopoietic and/or endo-
thelial markers such as c-kit, CD31, CD34, and VE-cadh- Interestingly, all of these markers have been shown to
be expressed in hematopoietic clusters as well as theerin are expressed on functional adult repopulating AGM
HSCs from normal embryos (Sanchez et al., 1996; North endothelial cells lining the dorsal aorta in midgestation
embryos (Bernex et al., 1996; Wood et al., 1997; Drakeet al., 2002), we performed flow cytometric analysis with
antibodies specific for these markers and for Sca-1 on and Fleming, 2000; Garcia-Porrero et al., 1998; Cai et
al., 2000; North et al., 2002). In the aorta-mesenchyme,cells from E11 Ly-6A GFP aorta-mesenchyme. Flow cy-
tometric profiles for UGRs are provided for comparison. c-kit cells make up 37%–51% of the GFP population.
As all AGM HSCs are known to express c-kit, theseAs shown in Figure 5, a large percentage of GFP cells
in the UGRs are Sca-1 (68%) as expected from the results strongly suggest that HSCs are in this double-
positive population. As expected from the endothelialimmunostaining results showing high coexpression of
Sca-1 and GFP in the mesonephric tubules. However, localization of GFP cells by microscopy, many GFP
HSCs in the Endothelium
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Figure 5. Representative FACS Profiles for E11 Aorta-Mesenchyme
and UGR Subregions
Figure 6. Hematopoietic Engraftment by Sorted GFP Cells afterCells from these two AGM subregions were obtained from Ly-6A
Explant Culture of Early E10 Ly-6A GFP AGMsGFP transgenic embryos and were stained with antibodies specific
(A) Experimental protocol. Twelve transgenic AGMs of the 31 to 34for Sca-1, c-kit, CD34, CD31, and VE-cadherin antigens. Three to
somite pair stage were cultured as explants for 3 days and harvested,five times 104 cells were analyzed for GFP (x axis) and surface
and the cells were sorted on the basis of GFP transgene expression.antigen (y axis) expression on a FACS Vantage SE. Dead cells were
Irradiated adult recipient mice were injected with either 3 ee or 1.5 eegated out from the analysis. Percentages of cells in each quadrant
of GFP (2.6  104 cells/ee) or GFP (3.5  105 cells/ee).are indicated and are representative of the profiles obtained from
(B) DNA PCR analysis, for the donor cell GFP transgene marker andtwo independent analyses.
the myogenin (myo) gene normalization control, showing low level,
restricted hematopoietic engraftment of a recipient mouse at 6
months after injection of 3 ee of GFP cells. Cells were obtainedcells in the aorta-mesenchyme are also CD34, CD31,
from each of the hematopoietic tissues indicated and from lineage-
and VE-Cadherin (63%, 64%, and 21% of all GFP specific sorts performed using antibodies directed against B cells,
cells, respectively). In combination with our data that all T cells, monocytes/granulocytes, and erythroid cells. PB, peripheral
normal AGM HSCs express c-kit, CD34, CD31, and VE- blood; BM, bone marrow; bL, bone marrow lymphoid; bM, bone
marrow myeloid; bE, bone marrow erythroid; S, spleen; sB, spleenCadherin (Sanchez et al., 1996; North et al., 2002), these
B cells; sT, spleen T cells; LN, lymph nodes; Th, thymus; and C,data indicate that the first HSCs are among the GFP
control transplanted with nontransgenic cells. Contribution controlscells in the aorta that coexpress these endothelial/
show signal expected from varying percentages of GFP transgene
hematopoietic markers. containing DNA. Percentage engraftment is indicated below each
lane. Quantitation was performed using ImageQuant.
Early E10 AGM Explants Contain GFP
Multipotential/Lymphoid Progenitors
Previously, we have been unable to obtain high level, blood, bone marrow, and spleen (Figure 6B). After sort-
ing cells from the bone marrow and spleen with antibod-multilineage hematopoietic repopulation from directly
transplanted AGM regions (Muller et al., 1994) or AGM ies specific for myeloid, erythroid, and B and T lymphoid
lineages, a predominance of donor-derived cells in theexplants (Medvinsky and Dzierzak, 1996) before the 35
somite pair stage. The appearance of a few GFP cells B lymphoid lineage was found. Only very low levels
(1%) of myeloid and erythroid lineage cells were found,in the AGM region of Ly-6A GFP transgenic embryos
beginning at the 24 somite pair stage (late E9), together suggesting that this animal was long-term repopulated
with a multipotent/lymphoid progenitor. Thus, the earlywith the finding that not all E11 AGM GFP cells are
HSCs, prompted us to test these early appearing GFP expression of GFP in the AGM region (before E10.5) may
represent cells that are the predecessors of high level,cells for other hematopoietic progenitor activity. We cul-
tured AGM explants from early E10 Ly-6A GFP embryos multilineage repopulating HSCs or unrelated progen-
itors.(31 to 34 somite pairs) for 3 days, sorted the GFP and
GFP cells, and transplanted these cells into irradiated
adult recipients (Figure 6A). At 4 months posttrans- Discussion
plantation, only those animals (two out of two) trans-
planted with GFP cells were positive for donor cell Ly-6A GFP Marks Definitive HSC Emergence in the
Dorsal Aorta and Vitelline and Umbilical Arteriesengraftment. Peripheral blood DNA PCR revealed levels
of engraftment of 1%–2% in these animals. Multilineage Unlike the Sca-1 surface glycoprotein, flow cytometric
sorting based on GFP expression reliably enriches foranalysis of hematopoietic tissues was performed at 6
months posttransplantation for one animal. Engraftment all AGM HSCs. This difference is due most likely to the
limiting nature of Sca-1 protein on the surface of theseof donor-derived cells was found mainly in the peripheral
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HSCs compared to a more intense fluorescence signal greater enrichment of aorta HSCs. In addition, close
observation of the GFP fluorescence profile of E11produced by GFP. Indeed, the transgenic mice contain
eight copies of the transgene as compared to the normal aorta-mesenchyme cells reveals two populations of
cells: a GFPhigh-expressing population representing ondiploid copy of the endogenous Ly-6A/E gene encoding
Sca-1. Furthermore, GFP is a cytoplasmic protein not average 0.3% of total cells and a GFPlow-expressing pop-
ulation representing 2.1% of total cells. As a means ofrequiring the processing steps necessary to get the
Sca-1 protein properly displayed on the cell surface (i.e., achieving greater enrichment of aorta HSCs, we have
begun to examine which population contains adult re-glycosylation, transport through the plasma membrane,
and GPI linkage). Thus, the Ly-6A GFP transgene ap- populating HSCs. Our preliminary results show adult
repopulating HSCs within the GFPhigh population. In thepears to be an optimally expressed reporter in AGM
HSCs and is an excellent marker for HSC isolation from best instance this may represent a further 10-fold enrich-
ment that, when put together with c-kit sorting, maythe embryo.
Flow cytometric analyses show that there are approxi- yield one HSC in 80 c-kitGFPhigh cells.
mately 1600 GFP cells within the E11 aorta-mesen-
chyme. While in transplantation studies all E11 AGM Specific Endothelial Localization of HSCs
aorta-mesenchyme HSCs are GFP, it is clear that not in the Midgestation Embryo
all 1600 GFP aorta-mesenchyme cells are functional The temporal and spatial expression pattern of the Ly-
HSCs. Outside the aorta subregion, we also found a 6A GFP transgene within the expected hematopoietic
significant percentage of GFP cells in the limb buds, sites of the midgestation mouse embryo is highly sug-
tail, and UGRs. In the E11 UGRs, we show here and in gestive of expression in HSCs. Indeed, in our functional
a previous study (de Bruijn et al., 2000) that there are no transplantation and fluorescence microscopy studies
HSCs even at high cell numbers transplanted. However, we have shown that all aorta-mesenchyme HSCs are
considering that HSCs can be detected in E12 UGRs or GFP and that they are localized to the single-cell layer
explant cultured E11 UGRs (de Bruijn et al., 2000), further lining the dorsal aorta. Furthermore, GFP expression is
studies must be performed to determine whether these found in the vitelline/umbilical arteries, which together
HSCs are GFP. Recent reports on the multipotentiality with the aorta, are the other sites within the embryo in
of stem cells for lineages outside the expected lineage which HSCs first appear at mid-E10. At later time points,
(reviewed in Wulf et al., 2001 and Morrison, 2001) led GFP expression is found in the E11 liver (Figure 2) and
us to analyze the hematopoietic potential of the other E11 yolk sac (Figure 3), again coincident with the appear-
GFP sites. If indeed the Ly-6A GFP transgene marks ance of HSCs as determined in previous studies (Muller
more totipotent stem cells, these cells in the developing et al., 1994; Medvinsky and Dzierzak, 1996). We have
limb and tail might be able to contribute to adult hemato- shown here that all HSCs in the E11 liver are GFP, and
poietic repopulation. In support of this, Godin and col- in other related studies (Ma et al., unpublished data) we
leagues (1999) found some hematopoietic colony-form- have found that all bone marrow HSCs in adult trans-
ing activity in limb bud tissues. When we sorted and genic mice are also GFP. Thus, in the various spatially
transplanted high ee of GFP limb bud cells, we found and temporally distinct sites tested, the Ly-6A GFP
no hematopoietic repopulation. Similarly, we have trans- transgene faithfully marks all HSCs.
planted high ee of cells from the tail and found no detect- The identification of the direct cellular precursors of
able adult hematopoietic repopulation (our unpublished HSCs is of great importance in understanding how the
data). However, given the low frequency of stem cells adult hematopoietic system is generated. Transverse
and the limited number of mice transplanted, additional sections through the E11 dorsal aorta reveal GFP cells
studies are warranted. only in the single layer of CD31 endothelial cells. No
GFP cells were found within the mesenchymal tissue
immediately surrounding and flanking the dorsal aorta.Enrichment of Aorta HSCs as They Emerge
during Midgestation Indeed, functional adult HSCs at this stage are CD31
(North et al., 2002). Thus, our data strongly suggest thatAt E11 there is at least one adult repopulating HSC in
1600 GFP aorta cells. Our FACS analysis data and HSCs are generated within the single layer of endothelial
cells lining the wall of the dorsal aorta and possess bothtransplantation results with sorted AGM cells using con-
ventional antibody-mediated enrichment suggest that endothelial and hematopoietic cell surface character-
istics.further enrichment can be achieved. For example, of
the 1600 GFP aorta cells, a smaller number are also At early E10, GFP expression in the aorta is limited
to the ventral endothelium, the area in which many inves-positive for c-kit, CD31, CD34, or VE-cadherin, markers
previously used for enrichment of AGM HSCs (Sanchez tigators have demonstrated emerging hematopoietic
clusters. On the basis of our data we cannot make theet al., 1996; North et al., 2002). Consistent with our trans-
plantation data for the aorta-mesenchyme in which not distinction between the aortic endothelium or the hema-
topoietic clusters as the site of HSC emergence sinceall HSCs are Sca-1, more GFP cells express c-kit than
Sca-1. Since it has already been shown that all AGM we have not been able to find any clusters in sections
from numerous GFP embryos analyzed. Despite ourHSCs are c-kit and we have shown here that all aorta
HSCs are GFP, a 50% enrichment can be achieved, inability to find clusters, if such cells were GFP we
would postulate that either these cells, the GFP cellsand only 800 c-kitGFP cells should be required for
complete multilineage adult recipient repopulation. within the endothelial layer, or both cell populations are
the functional adult repopulating HSCs. Indeed, our re-Three or four color sorting using c-kit and GFP expres-
sion together with CD34 and/or CD31 may allow an even cent findings using combinations of antibodies discern-
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quently subdissected into the aorta with its surrounding mesen-ing hematopoietic, endothelial, and mesenchymal cells
chyme and the UGRs using 27 gauge needles (Becton Dickinson,in the wild-type E11 AGM region demonstrate that the
San Jose, CA). Tissues were either incubated directly with collagen-HSCs exhibit not only a hematopoietic but also an endo-
ase (type I, Sigma; final concentration 0.12% v/v) for 1 hour at 37C
thelial surface phenotypic profile (North et al., 2002). in phosphate-buffered saline (PBS) supplemented with 10% fetal
Taken together, these results strongly suggest that adult calf serum (FCS) and penicillin/streptomycin or cultured as explants
for 3 days prior to collagenase digestion (Medvinsky and Dzierzak,repopulating HSC activity normally arises within the en-
1996). Cells were dispersed, washed, resuspended in PBSFCS,dothelial and/or hematopoietic cluster cells and not in
sorted, and transplanted intravenously into irradiated mice. Viablethe mesenchymal cell layer of the dorsal aorta. It is of
cell numbers were determined with a Bu¨rker hemocytometer usinginterest to note that North and colleagues revealed a
trypan blue. Cells were kept on ice at all times subsequent to colla-
population of adult-type HSCs in Runx1 haploinsuffi- genase digestion until the time of injection.
cient embryos with a mesenchymal surface phenotype,
which is absent from normal embryos, indicating that a Analysis of Long-Term Multilineage Repopulating Activity
full dose of Runx1 is required for the normal develop- Embryonic cell suspensions were assayed for the presence of defini-
tive HSCs by intravenous transfer into irradiated adult recipientsment of the adult repopulating HSCs in the aorta (North
(Dzierzak and de Bruijn, 2002; Muller et al., 1994; Miles et al., 1997;et al., 2002).
Medvinsky and Dzierzak, 1996). In brief, (C57BL/10 x CBA)F1 maleFinally, we have shown by explant culture of early E10
recipients were exposed to a split dose of 900 rad of 	 irradiation
AGM regions and subsequent GFP sorting and trans- from a 137Cs source. Adult (C57BL/10 x CBA)F1 spleen cells (2 
plantation that an earlier restricted hematopoietic pro- 105/mouse) were coinjected with the embryonic cells to promote
genitor is marked by the Ly-6A GFP transgene. Similar survival. Recipient mice were bled at 1 and4 months after transfer
and analyzed for donor contribution by donor marker-specific PCRlow level, adult repopulating cells in the AGM region
on peripheral blood DNA (Dzierzak and de Bruijn, 2002; Miles et al.,have been recently reported by Cumano and colleagues
1997; Muller et al., 1994). Reconstitution was evaluated by ethidium(2001), and others have reported neonatal repopulating
bromide staining of agarose gels and in some cases by Southern blot
hematopoietic cells in the AGM (Yoder et al., 1997) at hybridization as described (Dzierzak and de Bruijn, 2002; Medvinsky
time points earlier than E10.5 onset of HSC function. and Dzierzak, 1996; Muller et al., 1994). To test for long-term multilin-
Here we have observed the appearance of GFP expres- eage hematopoietic repopulation, genomic DNA was isolated from
peripheral blood, thymus, lymph node, splenic B and T cells, andsion in the AGM region and the vitelline/umbilical arteries
bone marrow myeloid, erythroid, and lymphoid cells. Percentageat times earlier than E10.5. Hence, these Ly-6A GFP-
donor-cell contribution was analyzed by ImageQuant using the myoexpressing cells may represent the direct precursors to
gene as the DNA normalization control.
the high level adult repopulating cells or alternatively
represent the differentiation products of the same or Fluorescent Antibody Surface Staining and Flow Cytometry
similar endothelial cohort that gives rise to the HSCs. All antibodies used in flow cytometric sorting and analysis were
Interestingly, an abundance of GFPlow-expressing cells obtained from Pharmingen. The monoclonal antibodies used were
directly conjugated with either phycoerythrin (PE) or biotin, or un-were found in the explant cultures of early E10 AGM
conjugated, and included PE-anti-c-kit (clone 2B8), PE-anti-Sca-1regions, and future sorting and transplantion experi-
(Ly-6A/E; clone E13-161.7), PE-anti-CD4 (clone GK1.5), PE-anti-ments will examine whether these restricted low level
CD8a (clone 53-6.7), PE-anti-B220 (CD45R; clone RA3-6B2), PE-
repopulating cells are correlated with GFP expression anti-Mac-1 (CD11b; clone M1/70), biotinylated CD31 (PECAM-1;
levels. clone MEC 13.3), CD34 (RAM34), and unconjugated purified VE-
In summary, we have shown here by transplantation Cadherin (CD144; clone 11D4.1). Single-cell suspensions were pre-
pared as described above. After incubation with specific antibodiesand immunofluorescence analyses of midgestational
for 30 min on ice, cells were washed twice and incubated with PE-Ly-6A GFP transgenic mouse AGM regions that all HSCs
conjugated streptavidin or PE-conjugated goat anti-rat IgG (mouse-in the aorta are GFP and that GFP-expressing cells are
absorbed) (Caltag Laboratories, Burlingame, CA) when required.
localized to the endothelial layer of the dorsal aorta but Cells were washed twice and filtered through a 45 m nylon mesh
not the underlying mesenchyme. This localization can screen prior to sorting. Hoechst 33258 (1 g/ml) or 2 g/ml 7AAD
now lead to an identification of the immediate precur- was added to identify dead cells. To determine the background
levels, cells were stained with appropriate immunoglobulin isotypesors to HSCs and a further understanding of the molecu-
controls (Pharmingen). During the entire staining procedure, PBSlar signals necessary for the emergence of these somatic
containing 10% FCS and penicillin/streptomycin was used. Cellsstem cells.
were sorted/analyzed using a FACS Vantage SE (Becton-Dickinson).
The purity of the sorted cells ranged from 80%–98%. For phenotypicExperimental Procedures
analysis of stained whole blood cell samples, suspensions were
treated for 10 min with FACS lysis solution (Becton-Dickinson) toTransgenic Mice and Embryo Generation
eliminate erythrocytes and washed before analysis.Timed matings were set up between Ly-6A-GFP, BL1b (Miles et al.,
1997), or line 72 (Strouboulis et al., 1992) transgenic male mice and
Immunohistochemical Staining and Confocal Microscopywild-type (C57BL/10  CBA)F1 females. The day of vaginal plug
Ly-6A GFP transgenic embryos were fixed in 2% paraformaldehyde/detection is day 0. For embryo generation, the transgene was always
PBS for 30 min at room temperature, equilibrated in 20% sucrose/inherited through the male parent to avoid contribution by geneti-
PBS overnight at 4C, quick frozen in Tissue Tek, and stored atcally marked maternal cells in transplantation assays. Transgenic
70C until use. After cryosectioning, tissues were treated in 100%embryos were typed on the basis of their GFP expression using
cold acetone for 10 min, washed with PBS (0.05% tween), blockedan Olympus IX70 fluorescent microscope. Animals were housed
with 0.5% BSA and 50% v/v Avidin D block solution (Vector Labora-according to institutional guidelines, and procedures were carried
tories Inc., Burlingame, CA) for 15 min, washed three times, blockedout in compliance with the Standards for Humane Care and Use of
with Biotin blocking solution (Vector Laboratories, Inc.) for 15 min,Laboratory Animals.
and washed three times. Subsequently, sections were incubated
with biotinylated antibodies for CD31 or Sca-1 (Pharmingen) at roomCell Preparations
temperature for 1 hr, washed three times, incubated with the detec-Pregnant mice were killed by cervical dislocation. Embryos were
isolated from the uterus, and AGMs were dissected and subse- tion reagent avidin TexasRed (Vector Laboratories Inc.) or Streptavi-
Immunity
682
din-Cy5 (Rockland, Gilbertsville, PS), washed three times, dehy- (1999). Stem cell emergence and hemopoietic activity are incompati-
ble in mouse intraembryonic sites. J. Exp. Med. 190, 43–52.drated in ethanol (from 70% to 100%), and mounted with vectashield
(Vector Laboratories, Burlingame, CA). For whole mount confocal Huang, H., and Auerbach, R. (1993). Identification and characteriza-
microscopy, AGM tissues were carefully dissected from E11 Ly- tion of hematopoietic stem cells from the yolk sac of the early mouse
6A GFP embryos, kept in PBS (containing 10% FCS), and directly embryo. Proc. Natl. Acad. Sci. USA 90, 10110–10114.
observed. Kamiura, S., Nolan, C.M., and Meruelo, D. (1992). Long-range physi-
cal map of the Ly-6 complex: mapping the Ly-6 multigene family
DNA Analysis by field-inversion and two-dimensional gel electrophoresis. Geno-
Genomic DNA (200 ng) from the peripheral blood of transplant recipi- mics 12, 89–105.
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.
alpha/beta and gamma requires a DNA element to which a tyrosine-DNA was subjected to an initial 5 min denaturation at 94C fol-
phosphorylated 91-kDa protein binds. Proc. Natl. Acad. Sci. USAlowed by 30 cycles of denaturation (1 min at 94C), annealing (2 min
90, 6806–6810.at 58C [-globin] or 55C [lacZ and GFP]), and elongation (2 min at
Kimura, S., Tada, N., Liu-Lam, Y., and Hammerling, U. (1984). Studies72C). Serial dilutions of blood DNA from a transgenic animal were
of the mouse Ly-6 alloantigen system. II. Complexities of the Ly-6used as a control to evaluate the levels of donor cell reconstitution
region. Immunogenetics 20, 47–56.in transplanted mice.
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Note Added in Proof
We have recently found some rare GFP clusters on the ventral
wall of the dorsal aorta in transverse sections from E10 Ly-6A GFP
transgenic embryos.
